A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis

被引:123
作者
Benito, C
Kim, WK
Chavarría, I
Hillard, CJ
Mackie, K
Tolón, RM
Williams, K
Romero, J [1 ]
机构
[1] Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid 28922, Spain
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogen, Boston, MA 02215 USA
[3] Francisco Vitoria Univ, Dept Biochem, Madrid 28223, Spain
[4] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
[5] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA
关键词
neuroinflammation; viral encephalitis; gliosis; endocannabinoids; immunohistochemistry; macaques;
D O I
10.1523/JNEUROSCI.3923-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent evidence supports the notion that the endocannabinoid system may play a crucial role in neuroinflammation. We explored the changes that some elements of this system exhibit in a macaque model of encephalitis induced by simian immunodeficiency virus. Our results show that profound alterations in the distribution of specific components of the endocannabinoid system occur as a consequence of the viral infection of the brain. Specifically, expression of cannabinoid receptors of the CB2 subtype was induced in the brains of infected animals, mainly in perivascular macrophages, microglial nodules, and T-lymphocytes, most likely of the CD8 subtype. In addition, the endogenous cannabinoid-degrading enzyme fatty acid amide hydrolase was overexpressed in perivascular astrocytes as well as in astrocytic processes reaching cellular infiltrates. Finally, the pattern of CB1 receptor expression was not modified in the brains of infected animals compared with that in control animals. These results resemble previous data obtained in Alzheimer's disease human tissue samples and suggest that the endocannabinoid system may participate in the development of human immunodeficiency virus-induced encephalitis, because activation of CB2 receptors expressed by immune cells is likely to reduce their antiviral response and thus could favor the CNS entry of infected monocytes.
引用
收藏
页码:2530 / 2536
页数:7
相关论文
共 43 条
  • [1] Benito C, 2003, J NEUROSCI, V23, P11136
  • [2] Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
    Carrier, EJ
    Kearn, CS
    Barkmeier, AJ
    Breese, NM
    Yang, WQ
    Nithipatikom, K
    Pfister, SL
    Campbell, WB
    Hillard, CJ
    [J]. MOLECULAR PHARMACOLOGY, 2004, 65 (04) : 999 - 1007
  • [3] Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212
    Croxford, JL
    Miller, SD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08) : 1231 - 1240
  • [4] Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60 -: Possible involvement of the CB2 receptor in cell differentiation
    Derocq, JM
    Jbilo, O
    Bouaboula, M
    Ségui, M
    Clère, C
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) : 15621 - 15628
  • [5] Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
    Felder, CC
    Nielsen, A
    Briley, EM
    Palkovits, M
    Priller, J
    Axelrod, J
    Nguyen, DN
    Richardson, JM
    Riggin, RM
    Koppel, GA
    Paul, SM
    Becker, GW
    [J]. FEBS LETTERS, 1996, 393 (2-3) : 231 - 235
  • [6] Role of endogenous cannabinoids in synaptic signaling
    Freund, TF
    Katona, I
    Piomelli, D
    [J]. PHYSIOLOGICAL REVIEWS, 2003, 83 (03) : 1017 - 1066
  • [7] Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
    Glass, M
    Dragunow, M
    Faull, RLM
    [J]. NEUROSCIENCE, 1997, 77 (02) : 299 - 318
  • [8] Grundy RI, 2001, MOL NEUROBIOL, V24, P29
  • [9] Cannabinoids and cell fate
    Guzmán, M
    Sánchez, C
    Galve-Roperh, I
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 95 (02) : 175 - 184
  • [10] International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, AC
    Barth, F
    Bonner, TI
    Cabral, G
    Casellas, P
    Devane, WA
    Felder, CC
    Herkenham, M
    Mackie, K
    Martin, BR
    Mechoulam, R
    Pertwee, RG
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 161 - 202